MARKET

NTRA

NTRA

Natera
NASDAQ

Real-time Quotes | Nasdaq Last Sale

30.57
+0.79
+2.65%
Opening 15:01 04/08 EDT
OPEN
30.21
PREV CLOSE
29.78
HIGH
31.20
LOW
29.62
VOLUME
232.89K
TURNOVER
--
52 WEEK HIGH
41.80
52 WEEK LOW
16.87
MARKET CAP
2.39B
P/E (TTM)
-16.9335
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NTRA stock price target is 42.00 with a high estimate of 49.00 and a low estimate of 32.00.

EPS

NTRA News

More
  • Coverage for Natera's Panorama® Prenatal Test Extended by Greater Than 20 Million Lives
  • PR Newswire · 2d ago
  • New Study Shows Benefit of Using Signatera Technology for Personalized Monitoring in Gastrointestinal Cancer
  • PR Newswire · 6d ago
  • Hedge Funds Have Never Been This Bullish On Natera Inc (NTRA)
  • Insider Monkey · 03/29 01:53
  • Natera Scores Relative Strength Rating Upgrade; Hits Key Benchmark
  • Investor's Business Daily · 03/23 23:13

Industry

Medical Equipment, Supplies & Distribution
+5.30%
Healthcare Equipment & Supplies
+4.50%

Hot Stocks

Symbol
Price
%Change

About NTRA

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).
More

Webull offers kinds of Natera Inc stock information, including NASDAQ:NTRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRA stock news, and many more online research tools to help you make informed decisions.